Edward M. Wolin, MD
Co-Director, Carcinoid and Neuroendocrine Tumor Program Medical Oncology, Samuel Oschin Cancer Center
Edward M. Wolin, MD, is Co-Director of the Cedars-Sinai Carcinoid and Neuroendocrine Tumor Program. With offices in the Samuel Oschin Comprehensive Cancer Institute, he directs a large patient care and clinical research program, including a weekly Carcinoid/Neuroendocrine Multidisciplinary Patient Management Conference. Dr. Wolin is board certified by the American Board of Internal Medicine with a subspecialty in medical oncology.
His research efforts are directed at finding treatments which are more effective and less toxic, including pasireotide, lanreotide, everolimus, other m-tor inhibitors, targeted radiation including peptide receptor radiotherapy with Lu-177, anti-angiogenic drugs, novel targeted biologic anti-cancer treatments, and targeted treatment of liver metastases. Dr. Wolin's research is also directed at development of new imaging and diagnostic procedures for carcinoid/neuroendocrine tumors.
Dr. Wolin has been cited as a "Best Doctor in America" and has been appointed to the advisory board of that organization. He received the Healthnetwork Foundation Service Excellence Award 2009, an annual award to 10 “top physicians in the country”. He is a member of Phi Beta Kappa, Sigma Xi Honorary Scientific Research Society, American Society of Clinical Oncology, American Society of Hematology, North American Neuroendocrine Tumor Society, European Neuroendocrine Tumor Society, Carcinoid Neuroendocrine Tumor Society of Canada and other professional societies. He is a journal reviewer for the Journal of Clinical Oncology, Pancreas, Journal of Gastrointestinal Cancer, Advances in Therapy, a grant reviewer for the American Society of Cancer Research and Study Chairman for Southwestern Cooperative Oncology Group (SWOG). He has authored numerous publications in peer-reviewed journals and book chapters. He presents regularly at major national and international meetings.
Dr. Wolin earned his medical degree at Yale University School of Medicine. He performed his internship, residency and a medical oncology fellowship at Stanford University Medical Center followed by a clinical fellowship at the National Cancer Institute in Bethesda, MD. Prior to joining Cedars-Sinai, Dr. Wolin was the Director of the Clinical Oncology Program at Washington University in St. Louis, Missouri.